X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/news/25/24084/nxera-pharma-inks-deal-with-handok-to-distribute-pivlaz-in-south-korea.html
https://www.globenewswire.com/news-release/2024/03/31/2854969/0/en/Nxera-Pharma-is-the-New-Name-for-Sosei-Group.html
https://www.globenewswire.com/news-release/2024/03/27/2852898/0/en/Sosei-Heptares-Confirms-Re-election-of-its-Board-and-Executive-Management-Team-and-the-Approval-of-Change-of-Company-Name-to-Nxera-Pharma.html
https://www.fiercebiotech.com/biotech/boehringer-boosts-schizophrenia-strategy-25m-eur-upfront-option-soseis-gpr52-agonists
https://www.globenewswire.com//news-release/2023/10/18/2762066/0/en/Sosei-Heptares-President-CEO-Chris-Cargill-Wins-Executive-of-the-Year-at-the-Citeline-Pharma-Intelligence-Awards-Japan-2023.html
https://www.globenewswire.com//news-release/2023/09/20/2746132/0/en/Sosei-Heptares-Adds-World-leading-Expertise-to-its-Scientific-Advisory-Board.html
https://www.globenewswire.com/news-release/2023/08/10/2722331/0/en/Sosei-Heptares-and-Cancer-Research-UK-Announce-the-Dosing-of-the-First-Patient-in-a-Phase-I-IIa-Trial-with-Cancer-Immunotherapy-Drug-HTL0039732.html
https://www.globenewswire.com/news-release/2023/08/04/2718743/0/en/Sosei-Heptares-Operational-Highlights-and-Consolidated-Results-for-the-Second-Quarter-and-First-Half-of-2023.html
https://www.globenewswire.com/news-release/2023/07/11/2702325/0/en/Sosei-Heptares-Webinar-Presentation-for-Q2-FY2023-Financial-Results.html
Market Place
Share 
